CD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia

Journal of Infectious Diseases

Volumn 211, Issue 5, 2015, Pages 835-845

  Parker, Dane ^a   Ryan, Chanelle L ^a   Alonzo, Francis ^b   Torres, Victor J ^b   Planet, Paul J ^a   Prince, Alice S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung; MRSA; Pneumonia; Staphylococcus aureus; T cell

Indexed keywords

CD134 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CELL PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VBETA18 PROTEIN; VBETA5 PROTEIN; VBETA6 PROTEIN; CYTOKINE; DNA BINDING PROTEIN; RAG2 PROTEIN, MOUSE; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERIAL STRAIN; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE STORM; DENDRITIC CELL; HISTOPATHOLOGY; IMMUNOMODULATION; INTRACELLULAR SIGNALING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENE DELETION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MOUSE; PATHOLOGY; SECRETION (PROCESS); STAPHYLOCOCCAL PNEUMONIA;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE DELETION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA, STAPHYLOCOCCAL; SUPERANTIGENS;

EID: 84942325395     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu525     Document Type: Article

References (50)

1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71.
2. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-62.
3. Louie J, Jean C, Chen TH, et al. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:1071-4.
4. Quinton LJ, Mizgerd JP. NF-kappaB and STAT3 signaling hubs for lung innate immunity. Cell Tissue Res 2011;343:153-65.
5. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005;3:948-58.
6. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010;107:5587-92.
7. Rigby KM, De Leo FR. Neutrophils in innate host defense against Staph-ylococcus aureus infections. Semin Immunopathol 2012;34:237-59.
8. Parker D, Planet PJ, Soong G, Narechania A, Prince A. Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains. PLoS Pathog 2014;10:e1003951.
9. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staph-ylococcus aureus pneumonia. Nat Med 2007;13:1405-6.
10. Cohen TS, Prince AS. Bacterial pathogens activate a common inflammatory pathway through IFNlambda regulation of PDCD4. PLoS Pathog 2013;9:e1003682.
11. Choi SM, McAleer JP, Zheng M, et al. Innate Stat3-mediated induction of the antimicrobial protein Reg3gamma is required for host defense against MRSA pneumonia. J Exp Med 2013;210:551-61.
12. Von Kockritz-Blickwede M, Rohde M, Oehmcke S, et al. Immunological mechanisms underlying the genetic predisposition to severe Staphylo-coccus aureus infection in the mouse model. Am J Pathol 2008;173:1657-68.
13. Schmaler M, Jann NJ, Ferracin F, Landmann R. T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation. J Immunol 2011;186:443-52.
14. Mollick JA, McMasters RL, Grossman D, Rich RR. Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med 1993;177:283-93.
15. Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Ann Rev Immunol 1999;17:435-66.
16. Hu DL, Omoe K, Sasaki S, et al. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J Infect Dis 2003;188:743-52.
17. Karauzum H, Chen G, Abaandou L, et al. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome. J Biol Chem 2012;287:25203-15.
18. Xu SX, McCormick JK. Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol 2012;2:52.
19. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006;367:731-9.
20. Wilson GJ, Seo KS, Cartwright RA, et al. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog 2011;7:e1002271.
21. Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013;13:227-42.
22. Monk IR, Shah IM, Xu M, Tan MW, Foster TJ. Transforming the un-transformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. MBio 2012;3:e00277-11.
23. Seo KS, Park JY, Terman DS, Bohach GA. A quantitative real time PCR method to analyze T cell receptor Vbeta subgroup expansion by staph-ylococcal superantigens. J Transl Med 2010;8:2.
24. Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2009;106:5883-8.
25. Li M, Cheung GY, Hu J, et al. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 2010;202:1866-76.
26. Montgomery CP, Boyle-Vavra S, Adem PV, et al. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 2008;198:561-70.
27. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:5113-20.
28. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 2010;125:39-49.
29. Orwin PM, Leung DY, Donahue HL, Novick RP, Schlievert PM. Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun 2001;69:360-6.
30. Orwin PM, Leung DY, Tripp TJ, et al. Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry 2002;41:14033-40.
31. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989;56:27-35.
32. Thomas D, Dauwalder O, Brun V, et al. Staphylococcus aureus superan-tigens elicit redundant and extensive human Vbeta patterns. Infect Immun 2009;77:2043-50.
33. Fraser JD, Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008;225:226-43.
34. Varshney AK, Mediavilla JR, Robiou N, et al. Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York. Appl Environ Microbiol 2009;75:6839-49.
35. Esashi E, Sekiguchi T, Ito H, Koyasu S, Miyajima A. Cutting edge: a possible role for CD4+ thymic macrophages as professional scavengers of apoptotic thymocytes. J Immunol 2003;171:2773-7.
36. Martin FJ, Parker D, Harfenist BS, Soong G, Prince A. Participation of CD11c (+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung. Infect Immun 2011;79:1898-904.
37. Kudva A, Scheller EV, Robinson KM, et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 2011;186:1666-74.
38. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010;10:479-89.
39. Mittrucker HW, Shahinian A, Bouchard D, Kundig TM, Mak TW. Induction of unresponsiveness and impaired T cell expansion by staph-ylococcal enterotoxin B in CD28-deficient mice. J Exp Med 1996;183:2481-8.
40. Muraille E, De Smedt T, Thielemans K, Urbain J, Moser M, Leo O. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Cell Immunol 1995;162:315-20.
41. Lando PA, Dohlsten M, Hedlund G, Brodin T, Sansom D, Kalland T. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity. Immunology 1993;80:236-41.
42. Saha B, Harlan DM, Lee KP, June CH, Abe R. Protection against lethal toxic shock by targeted disruption of the CD28 gene. J Exp Med 1996;183:2675-80.
43. Walunas TL, Lenschow DJ, Bakker CY, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405-13.
44. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mole Biol Rev 2012;76:16-32.
45. Garnier F, Tristan A, Francois B, et al. Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis 2006;12:498-500.
46. Holley MM, Kielian T. Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection. J Immunol 2012;188:1360-70.
47. Cheng P, Liu T, Zhou WY, et al. Role of gamma-delta T cells in host response against Staphylococcus aureus-induced pneumonia. BMC Immunol 2012;13:38.
48. Ahn DS, Parker D, Planet PJ, Nieto PA, Bueno SM, Prince A. Secretion of IL-16 through TNFR1 and calpain-caspase signaling contributes to MRSA pneumonia. Mucosal Immunol 2014; doi: 10.1038/mi.2014.24.
49. Marchant B, Brown J. Toxic shock syndrome and staphylococcal pneumonia. Lancet 1987;2:578.
50. Ramachandran G, Tulapurkar ME, Harris KM, et al. A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes. J Infect Dis 2013;207:1869-77.